Arcus Biosciences, Inc. (RCUS) vs Tarsus Pharmaceuticals, Inc. (TARS)
Arcus Biosciences, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Tarsus Pharmaceuticals, Inc. is the larger, with a market value of $3.6B against $3.2B — 1.1× the size. Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 105.2% against −55.3%. Tarsus Pharmaceuticals, Inc. has the higher net margin (−7.67% vs −393.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Tarsus Pharmaceuticals, Inc. leads on 12 and Arcus Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | RCUS | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.28% | 65.16% |
| Operating margin | (415.38%) | (8.00%) | 0.00% |
| Net margin | (393.16%) | (7.67%) | 0.00% |
| Free cash flow margin | (405.13%) | 9.24% | 0.00% |
| Return on equity | (90.82%) | (13.68%) | (57.72%) |
| Return on assets | (46.02%) | (8.40%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack